← Leaderboards
Ebbing Lautenbach
University Of Pennsylvania
$33,489,784
Attributed
$33,989,538
Total exposure
14
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
CDC$15,771,742 · 4
NIH$14,287,827 · 7
AHRQ$3,929,969 · 3
By mechanism
U54$14,909,909 · 3
R01$11,794,930 · 6
T32$3,861,607 · 1
R18$1,473,015 · 1
K24$852,507 · 1
K23$667,170 · 1
Top collaborators
- Julia E. Szymczak2 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Jennifer Han$1,371,797
- Michael Abbott Bachman$5,172,849
- Janet L Abrahm$997,985
- Yu-Xiao Yang$4,905,642
- Ravishankar Jayadevappa$1,078,333
Others in their field
Top investigators on “Antibiotics”
- Laurence H Baker · University Of Michigan At Ann Arbor$52,071,546
- Clarence Buddy Creech · Vanderbilt University Medical Center$43,812,829
- Taha E Taha · Johns Hopkins University$37,363,329
- Urs Ochsner · Crestone, Inc.$36,950,837
- Deborah T Hung · Massachusetts General Hospital$36,871,538
- Ryan Cirz · Revagenix, Inc.$35,410,554
Research focus
AntibioticsClinical EpidemiologyOrganismEvolutionTraining ProgramsCommunicable DiseasesEpidemiologyEscherichia ColiEscherichia Coli InfectionsInfectionResistance MechanismRisk FactorsResistanceDrug ResistanceFluoroquinolone ResistanceClinical ResearchMorbidity - Disease RateCharacteristicsClinical DataPathway InteractionsPlayComplexDisease /Disorder Proneness /RiskCohort Studies
Grant awards (66)
Southeastern Pennsylvania Adult and Pediatric Prevention Epicenter Network$598,649
U54 · FY2025 · CK · contact PI
Optimizing antibiotic selection in hematologic malignancy patients with reported beta-lactam allergy$499,510
R01 · FY2025 · HS · contact PI
Southeastern Pennsylvania Adult and Pediatric Prevention Epicenter Network$598,223
U54 · FY2024 · CK · contact PI
Optimizing antibiotic selection in hematologic malignancy patients with reported beta-lactam allergy$499,999
R01 · FY2024 · HS · contact PI
Southeastern Pennsylvania Adult and Pediatric Prevention Epicenter Network$244,448
U54 · FY2024 · CK · contact PI
Southeastern Pennsylvania Adult and Pediatric Prevention Epicenter Network$1,627,344
U54 · FY2023 · CK · contact PI
The clinical and molecular epidemiology of colistin-resistant carbapenem-resistant Enterobacteriaceae (CRE) in long-term acute care hospitals (LTACHs)$746,005
R01 · FY2023 · AI · contact PI
Infectious Diseases Clinical Epidemiology Training Program$401,099
T32 · FY2023 · AI · contact PI
The clinical and molecular epidemiology of colistin-resistant carbapenem-resistant Enterobacteriaceae (CRE) in long-term acute care hospitals (LTACHs)$755,729
R01 · FY2022 · AI · contact PI
Infectious Diseases Clinical Epidemiology Training Program$397,272
T32 · FY2022 · AI · contact PI
The clinical and molecular epidemiology of colistin-resistant carbapenem-resistant Enterobacteriaceae (CRE) in long-term acute care hospitals (LTACHs)$768,456
R01 · FY2021 · AI · contact PI
Infectious Diseases Clinical Epidemiology Training Program$379,124
T32 · FY2021 · AI · contact PI
Southeastern Pennsylvania Adult and Pediatric Prevention Epicenter Network$1,092,864
U54 · FY2020 · CK · contact PI
Southeastern Pennsylvania Adult and Pediatric Prevention Epicenter Network$544,932
U54 · FY2020 · CK · contact PI
Infectious Diseases Clinical Epidemiology Training Program$363,328
T32 · FY2020 · AI · contact PI
The clinical and molecular epidemiology of colistin-resistant carbapenem-resistant Enterobacteriaceae (CRE) in long-term acute care hospitals (LTACHs)$745,067
R01 · FY2019 · AI · contact PI
Southeastern Pennsylvania Adult and Pediatric Prevention Epicenter Network$600,000
U54 · FY2019 · CK · contact PI
Southestern Pennsylvania Adult and Pediatric Prevention Epicenter Network$498,350
U54 · FY2019 · CK · contact PI
Infectious Diseases Clinical Epidemiology Training Program$365,709
T32 · FY2019 · AI · contact PI
Southestern Pennsylvania Adult and Pediatric Prevention Epicenter Network$498,350
U54 · FY2018 · CK · contact PI
Infectious Diseases Clinical Epidemiology Training Program$354,598
T32 · FY2018 · AI · contact PI
Southestern Pennsylvania Adult and Pediatric Prevention Epicenter Network$38,896
U54 · FY2018 · CK · contact PI
Southestern Pennsylvania Adult and Pediatric Prevention Epicenter Network$499,569
U54 · FY2017 · CK · contact PI
Comparative and Cost Effectiveness of Strategies to Limit MRSA in Long Term Care$493,901
R01 · FY2017 · HS · contact PI
Infectious Diseases Clinical Epidemiology Training Program$347,841
T32 · FY2017 · AI · contact PI
Southestern Pennsylvania Adult and Pediatric Prevention Epicenter Network$5,168,935
U54 · FY2016 · CK · contact PI
Comparative and Cost Effectiveness of Strategies to Limit MRSA in Long Term Care$473,784
R01 · FY2016 · HS · contact PI
Infectious Diseases Clinical Epidemiology Training Program$312,472
T32 · FY2016 · AI · contact PI
Southeastern Pennsylvania Adult and Pediatric Prevention Epicenter Network$799,984
U54 · FY2015 · CK · contact PI
Comparative and Cost Effectiveness of Strategies to Limit MRSA in Long Term Care$489,760
R01 · FY2015 · HS · contact PI
Southeastern Pennsylvania Adult and Pediatric Prevention Epicenter Network$399,873
U54 · FY2015 · CK · contact PI
Infectious Diseases Clinical Epidemiology Training Program$334,242
T32 · FY2015 · AI · contact PI
Southeastern Pennsylvania Adult and Pediatric Prevention Epicenter Network$399,873
U54 · FY2014 · CK · contact PI
Urinary Infections due to Escherichia Coli with Reduced Quinolone Susceptibility$280,000
R21 · FY2014 · AI · contact PI
Infectious Diseases Clinical Epidemiology Training Program$198,725
T32 · FY2014 · AI · contact PI
Infectious diseases epidemiology training grant$407,197
T32 · FY2013 · AI · contact PI
Southeastern Pennsylvania Adult and Pediatric Prevention Epicenter Network$399,873
U54 · FY2013 · CK · contact PI
Mentoring and patient-oriented research in antimicrobial resistance$153,428
K24 · FY2013 · AI · contact PI
Urinary Infections due to Escherichia Coli with Reduced Quinolone Susceptibility$150,400
R21 · FY2013 · AI · contact PI
Multi-Drug Resistant Urinary Tract Infections in Ambulatory Settings$497,946
R18 · FY2012 · HS · contact PI
Southeastern Pennsylvania Adult and Pediatric Prevention Epicenter Network$399,873
U54 · FY2012 · CK · contact PI
Mentoring and patient-oriented research in antimicrobial resistance$152,450
K24 · FY2012 · AI · contact PI
Development of an Antibiotic Stewardship Bundle to Improve Antibiotic Prescribing$100,000
U54 · FY2012 · CK · contact PI
Multi-Drug Resistant Urinary Tract Infections in Ambulatory Settings$485,349
R18 · FY2011 · HS · contact PI
Southeastern Pennsylvania Adult and Pediatric Prevention Epicenter Network$399,873
U54 · FY2011 · CK · contact PI
Mentoring and patient-oriented research in antimicrobial resistance$186,014
K24 · FY2011 · AI · contact PI
Multi-Drug Resistant Urinary Tract Infections in Ambulatory Settings$489,720
R18 · FY2010 · HS · contact PI
Mentoring and patient-oriented research in antimicrobial resistance$182,169
K24 · FY2010 · AI · contact PI
Quinolone resistant E coli in long term care facilities$558,147
R01 · FY2009 · AG · contact PI
Mentoring and patient-oriented research in antimicrobial resistance$178,446
K24 · FY2009 · AI · contact PI
Quinolone resistant E coli in long term care facilities$562,943
R01 · FY2008 · AG · contact PI
Novel Application of Infection Control Strategies to Limit Transmission of ESBL'S$297,748
R01 · FY2008 · CI · contact PI
Clinical Impact of Quinolone-Resistant E.coli carriage$710,193
R01 · FY2007 · AI · contact PI
Quinolone resistant E coli in long term care facilities$553,684
R01 · FY2007 · AG · contact PI
Novel Application of Infection Control Strategies to Limit Transmission of ESBL'S$299,937
R01 · FY2007 · CI · contact PI
Clinical Impact of Quinolone-Resistant E.coli carriage$693,547
R01 · FY2006 · AI · contact PI
Quinolone resistant E coli in long term care facilities$551,324
R01 · FY2006 · AG · contact PI
Novel Application of Infection Control Strategies to Limit Transmission of ESBL'S$264,148
R01 · FY2006 · CI · contact PI
Clinical Impact of Quinolone-Resistant E.coli carriage$655,312
R01 · FY2005 · AI
Quinolone resistant E coli in long term care facilities$604,275
R01 · FY2005 · AG
Clinical Impact of Quinolone-Resistant E.coli carriage$571,461
R01 · FY2004 · AI
QUINOLONE RESISTANCE IN NOSOCOMIAL URINARY INFECTIONS$135,594
K23 · FY2004 · DK
QUINOLONE RESISTANCE IN NOSOCOMIAL URINARY INFECTIONS$135,594
K23 · FY2003 · DK
QUINOLONE RESISTANCE IN NOSOCOMIAL URINARY INFECTIONS$135,594
K23 · FY2002 · DK
QUINOLONE RESISTANCE IN NOSOCOMIAL URINARY INFECTIONS$130,194
K23 · FY2001 · DK
QUINOLONE RESISTANCE IN NOSOCOMIAL URINARY INFECTIONS$130,194
K23 · FY2000 · DK